Home' Australian Pharmacist : Australian Pharmacist November 2015 Contents Australian Pharmacist November 2015 I ©Pharmaceutical Society of Australia Ltd.
5. Responding to the threat of antimicrobial resistance:
Australia’s First National Antimicrobial Resistance Strategy
2015–2019. Commonwealth of Australia, 2015. ISBN:
978-1 -76007-191-2 . At: www.health.gov.au/internet/main/
6. Lim CJ, Stuart RL, Kong DC. Antibiotic use in residential
aged care facilities. Aust Fam Physician 2015;44:192–6 .
7. Stuart RL, Wilson J, Bellaard-Smith E, et al. Antibiotic use
and misuse in residential aged care facilities. Intern Med J
8. Hujer AM, Bethel CR, Hujer KM, Bonomo RA. Antibiotic
resistance in the institutionalized elderly. Clin Lab Med
9. Augustine S, Bonomo RA. Taking stock of infections and
antibiotic resistance in the elderly and long-term care
facilities: A survey of existing and upcoming challenges. Eur
J Microbiol Immunol 2011;1:190–7.
10. Wallis KA. Learning from no-fault treatment injury claims
to improve the safety of older patients. Ann Fam Med
11. Olivier P, Bertrand L, Tubery M, Lauque D, Montastruc JL,
Lapeyre-Mestre M. Hospitalizations because of adverse
drug reactions in elderly patients admitted through the
emergency department: a prospective survey. Drugs Aging
12. Boeker EB, Ram K, Klopotowska JE, et al. An individual
patient data meta-analysis on factors associated with
adverse drug events in surgical and non-surgical inpatients.
Br J Clin Pharmacol 2015;79:548–57.
13. Davies EA, O’Mahony MS. Adverse drug reactions in
special populations – the elderly. Br J Clin Pharmacol
14. Sakuma M, Kanemoto Y, Furuse A, Bates DW, Morimoto
T. Frequency and severity of adverse drug events by
medication classes: the JADE study. J Patient Saf 2015 doi:
15. Ventura MT, Laddaga R, Cavallera P, et al. Adverse drug
reactions as the cause of emergency department
admission: focus on the elderly. Immunopharmacol
16. Hines LE, Murphy JE. Potentially harmful drug-drug
interactions in the elderly: a review. Am J Geriatr
Pharmacother 2011;9:364–77 .
17. Vitry AI, Roughead EE, Ramsay EN, et al. Major bleeding risk
associated with warfarin and co-medications in the elderly
population. Pharmacoepidemiol Drug Saf 2011;20:1057-63 .
18. Di Bella S, Capone A, Musso M, et al. Clostridium difficile
infection in the elderly. Infez Med 2013;21:93–102.
19. Leffler DA, Lamont JT. Clostridium difficile infection. N Engl
J Med 2015;372:1539–48.
20. Antibiotic-associated diarrhoea [revised 2014 Oct]. In: eTG
complete [CD-ROM]. Melbourne: Therapeutic Guidelines
Limited; 2015 Jul, etg45.
21. Abou Chakra CN, Pepin J, Sirard S, Valiquette L. Risk
factors for recurrence, complications and mortality in
Clostridium difficile infection: a systematic review. PLoS
22. Keller JM, Surawicz CM. Clostridium difficile infection in the
elderly. Clin Geriatr Med 2014;30:79–93.
23. Marwick CA, Yu N, Lockhart MC, et al. Community-
associated Clostridium difficile infection among older
people in Tayside, Scotland, is associated with antibiotic
exposure and care home residence: cohort study
with nested case-control. J Antimicrob Chemother
24. Chopra T, Goldstein EJ. Clostridium difficile infection in
long-term care facilities: a call to action for antimicrobial
stewardship. Clin Infect Dis 2015;60 Suppl 2:S72–6 .
25. Gastroenteritis in residential aged-care facilities [revised
2014 Oct]. In: eTG complete [CD-ROM]. Melbourne:
Therapeutic Guidelines Limited; 2015 Jul, etg45.
26. Piacenti FJ, Leuthner KD. Antimicrobial stewardship and
Clostridium difficile-associated diarrhea. J Pharm Pract
27. Wenisch JM, Equiluz-Bruck S, Fudel M, et al. Decreasing
Clostridium difficile infections by an antimicrobial
stewardship program that reduces moxifloxacin use.
Antimicrob Agents Chemother 2014;58:5079–83 .
28. Jump RL, Olds DM, Seifi N, et al. Effective antimicrobial
stewardship in a long-term care facility through an
infectious disease consultation service: keeping a
LID on antibiotic use. Infect Control Hosp Epidemiol
29. Dyar OJ, Pagani L, Pulcini C. Strategies and challenges of
antimicrobial stewardship in long-term care facilities. Clin
Microbiol Infect 2015;21:10–9 .
30. Rhee SM, Stone ND. Antimicrobial stewardship in long-term
care facilities. Infect Dis Clin North Am 2014;28:237–46.
31. Moro ML, Gagliotti C. Antimicrobial resistance and
stewardship in long-term care settings. Future Microbiol
32. Klepser ME, Adams AJ, Klepser DG. Antimicrobial
stewardship in outpatient settings: leveraging innovative
physician-pharmacist collaborations to reduce antibiotic
resistance. Health Secur 2015;13:166–73.
33. Wise BL, Peloquin C, Choi H, et al. Impact of age, sex,
obesity, and steroid use on quinolone-associated tendon
disorders. Am J Med 2012;125:1228 e23–28.
34. Kaleagasioglu F, Olcay E. Fluoroquinolone-induced
tendinopathy: etiology and preventive measures. Tohoku J
Exp Med 2012;226:251–8 .
35. Tam PK, Ho CT. Fluoroquinolone-induced Achilles
tendinitis. Hong Kong Med J 2014;20:545–7 .
1. a thick middle layer of muscle
5. the regimen governing how much
and when a medicine is given
7. conscious recognition
11. actually taking medicines as
13. a sore head
14. how often does it happen?
2. can be good and bad but too much is
definitely not good for you
3. arriving early
4. how closely a person sticks to their
prescribed medicne regimen
6. when taking many medicines
8. not the disease not the medicine but
9. fancy term for sore muscles
10. synonym for complete
12. a disease that is there for the ‘long
Clues to some answers can be found in the Counselling in practice article on page 44.
Answers on page 80. This is not CPD accredited.
Links Archive Australian Pharmacist October 2015 Australian Pharmacist December 2015 Navigation Previous Page Next Page